" /> Emedastine Difumarate - CISMeF





Preferred Label : Emedastine Difumarate;

NCIt definition : The difumarate salt form of emedastine, a second generation, selective histamine H1 receptor antagonist with anti-allergic activity. Emedastine reversibly and competitively blocks histamine by binding to H1 receptors, thus blocking its downstream activity. As a result, this agent interferes with mediator release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition, emedastine may also inhibit the late-phase allergic reaction mediated through leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva. Emedastine does not affect adrenergic, dopamine, or serotonin receptors.;

UNII : 42MB94QOSM;

InChIKey : FWLKKPKZQYVAFR-LVEZLNDCSA-N;

CAS number : 87233-62-3;

Drug name : Emadine;

Chemical formula : C17H26N4O.2C4H4O4;

ChEBI ID : CHEBI:59865;

Details


You can consult :


Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.

" /> Emedastine Difumarate - CISMeF





Preferred Label : Emedastine Difumarate;

NCIt definition : The difumarate salt form of emedastine, a second generation, selective histamine H1 receptor antagonist with anti-allergic activity. Emedastine reversibly and competitively blocks histamine by binding to H1 receptors, thus blocking its downstream activity. As a result, this agent interferes with mediator release from mast cells either by inhibiting calcium ion influx across mast cell/basophil plasma membrane or by inhibiting intracellular calcium ion release within the cells. In addition, emedastine may also inhibit the late-phase allergic reaction mediated through leukotrienes or prostaglandins, or by producing an anti-platelet activating factor effect. Upon ocular administration, emedastine causes a dose-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva. Emedastine does not affect adrenergic, dopamine, or serotonin receptors.;

UNII : 42MB94QOSM;

InChIKey : FWLKKPKZQYVAFR-LVEZLNDCSA-N;

CAS number : 87233-62-3;

Drug name : Emadine;

Chemical formula : C17H26N4O.2C4H4O4;

ChEBI ID : CHEBI:59865;

Details


You can consult :


Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.